Created at Source Raw Value Validated value
Aug. 31, 2022, 1:30 a.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsThe first intervention group: 1000 mg of N-acetylcysteine by injection twice a day every 12 hours for two weeks as an IV and in the continuation of the intervention two weeks after discharge also at home four effervescent tablets of 500 mg of N-acetylcysteine twice in The day will be available to patients.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO RehabilitationFor four weeks, patients will use diaphragmatic breathing exercise and incentive spirometer every day according to the researcher's training. According to religion, the patient will lie on his back and a pillow will be placed under his head and a pillow under his knees, and then one hand will be placed on his chest and the other on his stomach. He will breathe deeply through his nose until his chest and stomach are large and full. and then the air will slowly come out of the mouth. This exercise will be done for one minute and then the patient will rest for 30 seconds and later the patient will use the incentive spirometry device. The patient will be taught to use the mouthpiece of the device place his mouth and inhale with maximum power and then hold the air in his mouth as much as possible (at least 5 seconds) and then let the air out slowly and do this 10 times and every one minute He will rest for 30 seconds. Exercise with spirometer will last 5 minutes. Exercises should be done 3 times a day (morning, noon and night). These exercises are taught and supervised by a respiratory muscle physiotherapist. Exercises are monitored through pulse. Oximeter and Borg scale are performed, in addition to that, incentive spirometry and Dia breathing exercise pattern are used Fragami will be available to the participants of the experimental group in the form of pamphlets and films.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsThe third intervention group: N-acetylcysteine \u200b\u200bgroup + respiratory muscles. For four weeks, patients will use diaphragmatic breathing exercise and incentive spirometer every day according to the researcher's training. According to religion, the patient will lie on his back and a pillow will be placed under his head and a pillow under his knees, and then one hand will be placed on his chest and the other on his stomach. He will breathe deeply through his nose until his chest and stomach are large and full. and then the air will slowly come out of the mouth. This exercise will be done for one minute and then the patient will rest for 30 seconds and later the patient will use the incentive spirometry device. The patient will be taught to use the mouthpiece of the device place his mouth and inhale with maximum power and then hold the air in his mouth as much as possible (at least 5 seconds) and then let the air out slowly and do this 10 times and every one minute He will rest for 30 seconds. Exercise with spirometer will last 5 minutes. Exercises should be done 3 times a day (morning, noon and night). These exercises are taught and supervised by a respiratory muscle physiotherapist. Exercises are monitored through pulse. Oximeter and Borg scale are performed, in addition to that, incentive spirometry and Dia breathing exercise pattern are used Fragami in the form of pamphlets and films will be provided to the participants of the experimental group, and at the same time, these people will receive 1000 mg of N-acetylcysteine \u200b\u200binjected twice a day every 12 hours for two weeks as an IV and in the continuation of the intervention two weeks after discharge. At home, four 500 mg N-acetylcysteine \u200b\u200beffervescent tablets will be provided to patients four times a day.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: The patients of this group did not receive any additional intervention and received the same drug and non-drug treatments as the intervention group, based on the opinion of the relevant treatment team according to the latest published version of the national protocol. This group received four 500 mg starch capsules daily. They will take it as a placebo for eight weeks. The placebo will be prepared by Karen Pharmaceutical Company.", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": 850, "treatment_name": "N-acetylcysteine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 230, "treatment_name": "Breathing exercise", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2598, "treatment_name": "Breathing exercise+n-acetylcysteine", "treatment_type": "Rehabilitation+respiratory agents", "pharmacological_treatment": "Non pharmacological treatment+pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]